New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine

Alain Lescoat, John Varga, Marco Matucci-Cerinic, Dinesh Khanna*

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS